Pregunta:
Rituximab moa
Autor: SuzukiRespuesta:
The Fab domain of rituximab binds to the CD20 antigen on the B lymphocytes, and its Fc domain recruits immune effector functions, inducing complement and antibodydependent, cell-mediated cytotoxicity of the B cells. The antibody is commonly used with other combinations of anticancer agents, such as cyclophosphamide, doxorubicin, vincristine (Oncovin ), and prednisone (CHOP).
0 / 5 (0 calificaciones)
1 answer(s) in total